trial

Antipsychotic Discontinuation in High-risk Subjects

NCTId NCT01758887
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Withdrawn
Enrollment 0 (actual)
Sponsored by Seoul National University Hospital
Primary completion 2016-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Withdrawn
Enrollment
0 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2012-12
Primary completion
2016-09
Eligibility
ALL · 16 Years · 40 Years

Interventions & indications

Drugs
—

Sponsors

Seoul National University HospitalLead Sponsor

Investigators

1
Jun Soo Kwon, MD, PhDPrincipal Investigator

Sites

1 total
Seoul, South Korea

Facts & assertions

4 sourced
Enrollment
0
Phase
NA
Primary Completion Date
2016-09
Status
WITHDRAWN
relationships
The graph out of here
lead_sponsor
Seoul National University Hospital
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Jun Soo Kwon, MD, PhD
person